000 04411nam a22005655i 4500
001 978-981-15-2017-4
003 DE-He213
005 20211012172312.0
007 cr nn 008mamaa
008 200304s2020 si | s |||| 0|eng d
020 _a9789811520174
_9978-981-15-2017-4
024 7 _a10.1007/978-981-15-2017-4
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
072 7 _aMJCL
_2thema
082 0 4 _a614.5999
_223
245 1 0 _aTheranostics Approaches to Gastric and Colon Cancer
_h[electronic resource] /
_cedited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar.
250 _a1st ed. 2020.
264 1 _aSingapore :
_bSpringer Singapore :
_bImprint: Springer,
_c2020.
300 _aXIII, 250 p. 26 illus., 17 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aDiagnostics and Therapeutic Advances in GI Malignancies,
_x2662-2696
505 0 _aChapter 1. Therapeutic role of Phytochemicals in Colorectal cancer -- Chapter 2. Adiponectin Signaling In Colorectal Cancer -- Chapter 3. Role of Matrix Metalloproteinases in Colorectal Cancer -- Chapter 4. The Role of Hypoxia-Inducible Factor 1- Alpha in Colorectal Cancer -- Chapter 5. Mechanisms and pathways of metabolic reprogramming of colorectal cancer -- Chapter 6. Targeting metabolic reprogramming of colorectal cancer -- Chapter 7. Understanding colorectal cancer: the basics -- Chapter 8. Molecular signaling pathways involved in gastric cancer chemoresistance -- Chapter 9. Meta-analysis reveals no significant association of EPHX1 Tyr113His and His139Arg polymorphisms with the colorectal cancer risk -- Chapter 10. Meta-analysis of genetic variants in alcohol metabolizing enzymes and their association with colorectal cancer risk -- Chapter 11. Gut microbiota as signatures in non-communicable diseases and mucosal immunity -- Chapter 12. Immunotherapy for Colon Cancer: Recent Perspectives -- Chapter 13. Nanotechnology Applications in Gastric cancer. .
520 _aThis book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.
650 0 _aCancer research.
650 0 _aGastroenterology .
650 0 _aOncology  .
650 0 _aGenetics.
650 1 4 _aCancer Research.
_0https://scigraph.springernature.com/ontologies/product-market-codes/B11001
650 2 4 _aGastroenterology.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H33061
650 2 4 _aOncology.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H33160
650 2 4 _aGenetics and Genomics.
_0https://scigraph.springernature.com/ontologies/product-market-codes/L32000
700 1 _aRaju, Ganji Seeta Rama.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBhaskar, L.V.K.S.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789811520167
776 0 8 _iPrinted edition:
_z9789811520181
776 0 8 _iPrinted edition:
_z9789811520198
830 0 _aDiagnostics and Therapeutic Advances in GI Malignancies,
_x2662-2696
856 4 0 _uhttps://doi.org/10.1007/978-981-15-2017-4
912 _aZDB-2-SBL
912 _aZDB-2-SXB
950 _aBiomedical and Life Sciences (SpringerNature-11642)
950 _aBiomedical and Life Sciences (R0) (SpringerNature-43708)
999 _c548773
_d548708